Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Prostate Cancer

Free Subscription 11.03.2024 1 Anticancer Res 5 BMC Cancer 1 BMC Urol 1 Br J Cancer 1 Cancer 1 Cancer Imaging 1 Cancer Lett 1 Discov Oncol 1 Eur Urol 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 3 Int J Urol 1 J Clin Oncol 1 J Nucl Med 2 Oncogene 1 Oncology 2 PLoS One 1 Prostate 1 Radiol Artif Intell 2 Radiology 1 Urol Int 2 Urology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Anticancer Res

1. HERNANDEZ-VALENCIA CG, Rodriguez-Martinez G, Carriles-Perez AM, Gonzalez-Perez D, et al
   Antiproliferative and Antimigratory Activity of Poly-gallic Acid in Cancer Cell Lines.
   Anticancer Res. 2024;44:1201-1208.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. SHEN Z, Yao C, Bai Y, Wang Y, et al
   Transversal approach via a bladder neck and prostate combined longitudinal incision versus standard approach of robotic-assisted radical prostatectomy for localized prostate cancer: a retrospective analysis.
   BMC Cancer. 2024;24:313.
   PubMed         Abstract available
   
   
3. CUI F, Qiu Y, Xu W, Zou C, et al
   Pretreatment prostate-specific antigen density as a predictor of biochemical recurrence in patients with prostate cancer: a meta-analysis.
   BMC Cancer. 2024;24:305.
   PubMed         Abstract available
   
   
4. MIYAZAWA Y, Koike H, Oka D, Kawamura H, et al
   Comparison of sexual function after robot-assisted radical prostatectomy and carbon-ion radiotherapy for Japanese prostate cancer patients using propensity score matching.
   BMC Cancer. 2024;24:300.
   PubMed         Abstract available
   
   
5. FU Q, Luo L, Hong R, Zhou H, et al
   Radiogenomic analysis of ultrasound phenotypic features coupled to proteomes predicts metastatic risk in primary prostate cancer.
   BMC Cancer. 2024;24:290.
   PubMed         Abstract available
   
   
6. KHALIL MIM, Ashour A, Shaala RS, Allam RM, et al
   Effect of health belief model-based educational intervention on prostate cancer prevention; knowledge, practices, and intentions.
   BMC Cancer. 2024;24:289.
   PubMed         Abstract available
   
   

   
   BMC Urol

7. YU C, Jingzhen Z, Luqiang Z, Xiaojuan Y, et al
   Coping strategies mediate the relationship between fear of cancer recurrence and quality of life in postoperative patients with prostate cancer: a multicentre survey.
   BMC Urol. 2024;24:49.
   PubMed         Abstract available
   
   

   
   Br J Cancer

8. GNANAPRAGASAM V
   Shifting the paradigm in the management of early prostate cancer.
   Br J Cancer. 2024 Mar 6. doi: 10.1038/s41416-024-02641.
   PubMed         Abstract available
   
   

   
   Cancer

9. BENADADA F, Saad F, Delouya G, Taussky D, et al
   Charles Brenton Huggins: A historical review of the Nobel laureate's pioneering discoveries.
   Cancer. 2024;130:1019-1024.
   PubMed         Abstract available
   
   

   
   Cancer Imaging

10. YAZDANI E, Karamzadeh-Ziarati N, Cheshmi SS, Sadeghi M, et al
    Automated segmentation of lesions and organs at risk on [(68)Ga]Ga-PSMA-11 PET/CT images using self-supervised learning with Swin UNETR.
    Cancer Imaging. 2024;24:30.
    PubMed         Abstract available
    
    

    
    Cancer Lett

11. RODRIGO-FAUS M, Vincelle-Nieto A, Vidal N, Puente J, et al
    CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis.
    Cancer Lett. 2024 Mar 1:216776. doi: 10.1016/j.canlet.2024.216776.
    PubMed         Abstract available
    
    

    
    Discov Oncol

12. WANG L, Zheng YB, Yin S, Li KP, et al
    Causal relationship between gut microbiota and prostate cancer contributes to the gut-prostate axis: insights from a Mendelian randomization study.
    Discov Oncol. 2024;15:58.
    PubMed         Abstract available
    
    

    
    Eur Urol

13. GOLIJANIN B, Mega A, Golijanin D
    Re: Ivo I. de Vos II, Sebastiaan Remmers, Renee Hogenhout, Monique J. Roobol, ERSPC Rotterdam Study Group. Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Scr
    Eur Urol. 2024 Feb 29:S0302-2838(24)00081-2. doi: 10.1016/j.eururo.2024.
    PubMed        
    
    

    
    Int J Cancer

14. ZHANG Y, Stopsack KH, Song M, Mucci LA, et al
    Healthy dietary patterns and risk of prostate cancer in men at high genetic risk.
    Int J Cancer. 2024 Mar 1. doi: 10.1002/ijc.34898.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

15. PATEL KR, Rydzewski NR, Schott E, Cooley-Zgela T, et al
    A Phase I Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2024 Feb 28:S0360-3016(24)00323.
    PubMed         Abstract available
    
    

    
    Int J Urol

16. BLAS L, Shiota M, Tanegashima T, Kobayashi S, et al
    Survival beyond cabazitaxel for metastatic castration-resistant prostate cancer.
    Int J Urol. 2024 Mar 5. doi: 10.1111/iju.15449.
    PubMed        
    
    
17. KAWASE M, Kato D, Tobisawa Y, Iinuma K, et al
    Efficacy and safety of combination neoadjuvant chemo-hormonal therapy and robot-assisted radical prostatectomy for oligometastatic prostate cancer.
    Int J Urol. 2024 Mar 7. doi: 10.1111/iju.15448.
    PubMed        
    
    
18. GOTO Y
    Editorial Comment on Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries.
    Int J Urol. 2024 Mar 8. doi: 10.1111/iju.15444.
    PubMed        
    
    

    
    J Clin Oncol

19. HEISS BL, Chang E, Gao X, Truong T, et al
    US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer.
    J Clin Oncol. 2024 Mar 7:JCO2302182. doi: 10.1200/JCO.23.02182.
    PubMed         Abstract available
    
    

    
    J Nucl Med

20. HARTRAMPF PE, Huttmann T, Seitz AK, Kubler H, et al
    Prognostic Performance of RECIP 1.0 Based on [(18)F]PSMA-1007 PET in Prostate Cancer Patients Treated with [(177)Lu]Lu-PSMA I&T.
    J Nucl Med. 2024 Mar 7:jnumed.123.266702. doi: 10.2967/jnumed.123.266702.
    PubMed         Abstract available
    
    

    
    Oncogene

21. ARRIAGA JM, Ronaldson-Bouchard K, Picech F, Nunes de Almeida F, et al
    In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis.
    Oncogene. 2024 Mar 7. doi: 10.1038/s41388-024-02995.
    PubMed         Abstract available
    
    
22. LI J, Hong Z, Zhang J, Zheng S, et al
    Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide.
    Oncogene. 2024;43:744-757.
    PubMed         Abstract available
    
    

    
    Oncology

23. SCHAULIN MS, Delouya G, Zwahlen D, Taussky D, et al
    Tracing the Evolution of Prostate Brachytherapy in the 20th Century.
    Oncology. 2024;102:283-290.
    PubMed         Abstract available
    
    

    
    PLoS One

24. TAKAKUSAGI Y, Koge H, Kano K, Shima S, et al
    Five-year clinical outcomes of scanning carbon-ion radiotherapy for prostate cancer.
    PLoS One. 2024;19:e0290617.
    PubMed         Abstract available
    
    
25. DARBA J, Ascanio M
    Prostate cancer in Spain: A retrospective database analysis of hospital incidence and the direct medical costs.
    PLoS One. 2024;19:e0298764.
    PubMed         Abstract available
    
    

    
    Prostate

26. BRENNEN WN, Le Magnen C, Karkampouna S, Anselmino N, et al
    Defining the challenges and opportunities for using patient-derived models in prostate cancer research.
    Prostate. 2024 Mar 7. doi: 10.1002/pros.24682.
    PubMed         Abstract available
    
    

    
    Radiol Artif Intell

27. HU L, Guo X, Zhou D, Wang Z, et al
    Development and Validation of a Deep Learning Model to Reduce the Interference of Rectal Artifacts in MRI-based Prostate Cancer Diagnosis.
    Radiol Artif Intell. 2024 Mar 6:e230362. doi: 10.1148/ryai.230362.
    PubMed         Abstract available
    
    

    
    Radiology

28. GHAI S, Finelli A, Corr K, Lajkosz K, et al
    MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial.
    Radiology. 2024;310:e231473.
    PubMed         Abstract available
    
    
29. WOODRUM DA
    Less Is More: MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer.
    Radiology. 2024;310:e240258.
    PubMed        
    
    

    
    Urol Int

30. HU S, Xiong X, Qiu S, Li J, et al
    Comparing efficacies of different exercises on androgen deprivation therapy adverse effects in prostate cancer patients: a network meta-analysis.
    Urol Int. 2024 Mar 2. doi: 10.1159/000538114.
    PubMed         Abstract available
    
    

    
    Urology

31. ALBERS P, Bennett J, Evans M, Martin ES, et al
    Value of Incremental Biopsy Cores for Microultrasound Targeted Prostate Biopsies.
    Urology. 2024;184:142-148.
    PubMed         Abstract available
    
    
32. SHAH MS, Lallas CD
    Editorial Commentary on Improving Racial Disparities in Prostate Cancer.
    Urology. 2024 Feb 29:S0090-4295(24)00123-7. doi: 10.1016/j.urology.2024.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.